LYEL - Lyell Immunopharma President and CEO Acquires 7500000 Shares After Exercising Company Stock Options | Benzinga
Lynn Seely, President and CEO at Lyell Immunopharma (NASDAQ:LYEL), reported a large exercise of company stock options on November 21, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Seely, President and CEO at Lyell Immunopharma, a company in the Health Care sector, just exercised stock options worth 7,500,000 shares of LYEL stock with an exercise price of $3.28.
Lyell Immunopharma shares are trading down 1.03% at $1.92 at the time of this writing on Tuesday morning. Since the current price is $1.92, this makes Seely's 7,500,000 shares worth $14,400,000.
Now trade stocks online commission free with Charles Schwab, ...